2021 Insights Across Retinal Diseases, Viral & Non-Viral Vector Platforms for Gene Therapies, Allogeneic Cell Therapy, and More
May 18, 2021 07:13 ET
|
Research and Markets
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "2021 Growth Opportunities in Cell & Gene Therapies, Retinal Diseases, Drug Delivery Platforms, Plant-based Drugs, Cardiac Health, AI-based Devices,...